225 related articles for article (PubMed ID: 22500958)
41. Nuclear accident countermeasures: iodine prophylaxis. Report of the UK Working Group on Iodine Prophylaxis following Nuclear Accidents.
Rep Health Soc Subj (Lond); 1991; 39():1-63. PubMed ID: 1924993
[No Abstract] [Full Text] [Related]
42. PROBLEMATIC ASPECTS, COMPLICATIONS, MISCONCEPTIONS AND DEBATABLE ISSUES OF IODINE PROPHYLAXIS IN RADIATION EVENTS (REVIEW).
Afanasiev DE; Kaminskyi OV; Loganovska TK; Kopylova OV; Chikalova IG; Muraviova IM; Dombrovska NS
Probl Radiac Med Radiobiol; 2022 Dec; 27():25-59. PubMed ID: 36582080
[TBL] [Abstract][Full Text] [Related]
43. Non-malignant thyroid disease after exposure to radioactive elements during nuclear explosion: a neglected issue.
Wiwanitkit V
Kulak Burun Bogaz Ihtis Derg; 2012; 22(2):119-21. PubMed ID: 22548272
[TBL] [Abstract][Full Text] [Related]
44. The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association.
Becker DV; Braverman LE; Dunn JT; Gaitan E; Gorman C; Maxon H; Schneider AB; Van Middlesworth L; Wolff J
JAMA; 1984 Aug; 252(5):659-61. PubMed ID: 6737670
[TBL] [Abstract][Full Text] [Related]
45. Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection.
Valentin J;
Ann ICRP; 2005; 35(1):1-110, iii-iv. PubMed ID: 16164984
[TBL] [Abstract][Full Text] [Related]
46. [Iodine prophylaxis to prevent radiation damage following nuclear disasters].
Frankfort SV; Roos JC; Franssen EJ
Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1641-4. PubMed ID: 12966630
[TBL] [Abstract][Full Text] [Related]
47. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia.
Jacob P; Kenigsberg Y; Zvonova I; Goulko G; Buglova E; Heidenreich WF; Golovneva A; Bratilova AA; Drozdovitch V; Kruk J; Pochtennaja GT; Balonov M; Demidchik EP; Paretzke HG
Br J Cancer; 1999 Jul; 80(9):1461-9. PubMed ID: 10424752
[TBL] [Abstract][Full Text] [Related]
48. [Changes of the thyroid under the influence of irradiation].
Voronetskiĭ IB; Zubovskiĭ GA
Med Radiol (Mosk); 1990 Jun; 35(6):33-6. PubMed ID: 2192218
[No Abstract] [Full Text] [Related]
49. The perinatal thyroid in iodine deficient regions: risks of radioiodines--hazards of stable iodine overload. A study in the newborn rat.
Hindié E; Walker F; Petiet A; Bourahla K; Galle P; Colas-Linhart N
Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):411-6. PubMed ID: 11441946
[TBL] [Abstract][Full Text] [Related]
50. Protection of the infant thyroid from radioactive contamination by the administration of stable iodide. An experimental evaluation in chimpanzees.
Noteboom JL; Hummel WA; Broerse JJ; de Vijlder JJ; Vulsma T; van Bekkum DW
Radiat Res; 1997 Jun; 147(6):698-706. PubMed ID: 9189168
[TBL] [Abstract][Full Text] [Related]
51. Cancer consequences of the Chernobyl accident: 20 years on.
Cardis E; Howe G; Ron E; Bebeshko V; Bogdanova T; Bouville A; Carr Z; Chumak V; Davis S; Demidchik Y; Drozdovitch V; Gentner N; Gudzenko N; Hatch M; Ivanov V; Jacob P; Kapitonova E; Kenigsberg Y; Kesminiene A; Kopecky KJ; Kryuchkov V; Loos A; Pinchera A; Reiners C; Repacholi M; Shibata Y; Shore RE; Thomas G; Tirmarche M; Yamashita S; Zvonova I
J Radiol Prot; 2006 Jun; 26(2):127-40. PubMed ID: 16738412
[TBL] [Abstract][Full Text] [Related]
52. Risk perception of the pre-distribution of stable iodine to guardians of children living around the Genkai Nuclear Power Plant, Saga Prefecture, Japan.
Matsunaga H; Orita M; Taira Y; Takamura N
PLoS One; 2021; 16(5):e0250570. PubMed ID: 33983948
[TBL] [Abstract][Full Text] [Related]
53. [Chernobyl, attempt at a health evaluation].
Bertin M; Hubert D; Lallemand J
Bull Cancer Radiother; 1994; 81(4):275-83. PubMed ID: 7702911
[No Abstract] [Full Text] [Related]
54. Recommendations on the use of potassium iodide as a thyroid-blocking agent in radiation accidents: an FDA update.
Shleien B; Halperin JA; Bilstad JM; Botstein P; Dutra EV
Bull N Y Acad Med; 1983 Dec; 59(10):1009-19. PubMed ID: 6582962
[No Abstract] [Full Text] [Related]
55. Protection of the maternal and fetal thyroid from radioactive contamination by the administration of stable iodide during pregnancy. An experimental evaluation in chimpanzees.
Noteboom JL; Hummel WA; Broerse JJ; de Vijlder JJ; Vulsma T; Jansen JT; van Bekkum DW
Radiat Res; 1997 Jun; 147(6):691-7. PubMed ID: 9189167
[TBL] [Abstract][Full Text] [Related]
56. Reactor accidents. Public health strategies and their medical implications.
Becker DV
JAMA; 1987 Aug; 258(5):649-54. PubMed ID: 3612987
[TBL] [Abstract][Full Text] [Related]
57. Indications for using potassium iodide to protect the thyroid from low level internal irradiation.
Robbins J
Bull N Y Acad Med; 1983 Dec; 59(10):1028-38. PubMed ID: 6582964
[No Abstract] [Full Text] [Related]
58. Thyroid cancer following exposure to radioactive iodine.
Robbins J; Schneider AB
Rev Endocr Metab Disord; 2000 Apr; 1(3):197-203. PubMed ID: 11705004
[TBL] [Abstract][Full Text] [Related]
59. Dutch distribution zones of stable iodine tablets based on atmospheric dispersion modelling of accidental releases from nuclear power plants.
Kok-Palma Y; Leenders M; Meulenbelt J
Radiat Prot Dosimetry; 2010 Aug; 140(3):234-41. PubMed ID: 20332130
[TBL] [Abstract][Full Text] [Related]
60. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
Mattsson S; Johansson L; Jönsson H; Nosslin B
Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
